John E. Harrison
Kilmington Common
Kilmington, ENG, United Kingdom
Kilmington, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
A Phase 2 randomised, double-blind, placebo-controlled trial of emestedastat in patients with major depressive disorder and cognitive impairment.
Journal: The British journal of psychiatry : the journal of mental science
Published: July 17, 2026
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.
Journal: Nature medicine
Published: June 17, 2025
Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 08, 2025
Exploring the potential of digital biomarkers as a measure of brain health 'capital'.
Journal: NPJ digital medicine
Published: March 03, 2025
Digital biomarkers: Redefining clinical outcomes and the concept of meaningful change.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: October 22, 2024
Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 30, 2024
Smartphone- and Tablet-Based Tools to Assess Cognition in Individuals With Preclinical Alzheimer Disease and Mild Cognitive Impairment: Scoping Review.
Journal: Journal of medical Internet research
Published: August 12, 2024
Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease.
Journal: Clinical pharmacology in drug development
Published: July 05, 2024
Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology.
Journal: Alzheimer's research & therapy
Published: June 21, 2024
Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11β-HSD1 Inhibitor Xanamem® for Mild Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: June 07, 2024
Evaluation of effect of cooled haemodialysis on cognition in patients with end-stage kidney disease (ECHECKED) feasibility randomised controlled trial results.
Journal: BMC nephrology
Published: May 31, 2024
"Time Saved" Calculations to Improve Decision-Making in Progressive Disease Studies.
Journal: The journal of prevention of Alzheimer's disease
Published: May 06, 2024
Last Updated: 09/26/2026